Estradiol sulfamate
Estradiol sulfamate (E2MATE; developmental code names J995, PGL-2, PGL-2001, ZK-190628, others), or estradiol-3-O-sulfamate, is a steroid sulfatase (STS) inhibitor which is under development for the treatment of endometriosis. It is the C3 sulfamate ester of estradiol, and was originally thought to be a prodrug of estradiol.
Clinical data | |
---|---|
Other names | E2MATE; Estradiol-3-O-sulfamate; (E2-SO2-(NH2); J995; ES-J995; PGL-2; PGL-2001; ZK-190628; BLE-00084; 17β-Hydroxyestra-1,3,5(10)-trien-3-yl sulfamate |
Routes of administration | By mouth |
Drug class | Steroid sulfatase inhibitor |
Pharmacokinetic data | |
Elimination half-life | 18 days |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C18H25NO4S |
Molar mass | 351.46 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.